Acadia Pharmaceuticals





Ebit Zmiana Data
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
ALKERMES USD 89.08M 3.9M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Cytokinetics USD -178.37M 11.61M 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Incyte USD 383.88M 47.44M 2025-12
J&J USD 5.11B 2.3B 2025-12
Moderna USD -857M 597M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Pfizer USD 4.65B 71M 2025-12
Prothena USD -39.76M 12.25M 2025-09
PTC Therapeutics USD -81.62M 85.11M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12


Acadia Pharmaceuticals - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.